AUTL vs EDIT: stock comparison and AI forecast
Autolus Therapeutics Plc (AUTL) and Editas Medicine, Inc. (EDIT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AUTL Autolus Therapeutics Plc
- Price
- $1.42 -13.7% · 6M
- Market Cap
- $377M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
EDIT Editas Medicine, Inc.
- Price
- $2.60 -14.5% · 6M
- Market Cap
- $399M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AUTL and EDIT have similar market capitalizations ($377M and $399M).
- Over the last six months AUTL returned -13.7% and EDIT -14.5%.
- AUTL carries 2.37 times debt per unit of equity, against 1.25 times for EDIT.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AUTL | EDIT |
|---|---|---|
| Market Cap | $377M | $399M |
| P/B Ratio | 3.38x | 3.79x |
| EPS | $-1.05 | $-1.32 |
| Book Value/Share | $0.42 | $0.69 |
| Revenue/Share | $0.38 | $0.29 |
| FCF/Share | $-0.87 | $-0.78 |
Profitability & Margins
| Metric | AUTL | EDIT |
|---|---|---|
| ROIC | – | -44.9% |
| Gross Margin | 1.1% | – |
| Operating Margin | – | -171.7% |
| EBT Margin | – | -171.7% |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | AUTL | EDIT |
|---|---|---|
| Current Ratio | 4.89x | 3.19x |
| Quick Ratio | 4.40x | – |
| D/E Ratio | 2.37x | 1.25x |
| Financial Leverage | – | 2.25x |
| Interest Coverage | 16.4x | -17.5x |
| Working Capital | $267M | $150M |
Cash Flow
| Metric | AUTL | EDIT |
|---|---|---|
| Operating Cash Flow | -$226M | -$120M |
| Free Cash Flow | -$233M | -$121M |
| Capital Spending | -$7M | -$690K |
| FCF/Sales | -232.4% | -272.9% |
| CapEx/Sales | 7.1% | 1.6% |
Operational Efficiency
| Metric | AUTL | EDIT |
|---|---|---|
| Asset Turnover | – | 0.19x |
| Receivables Turnover | 2.3x | 16.2x |
| Inventory Turnover | 3.0x | – |
| Fixed Assets Turnover | 1.6x | 17.2x |
| Days Sales Outstanding | 162 days | 23 days |
| Days Inventory | 123 days | – |
| Payables Period | 5 days | – |
| Cash Conversion Cycle | 280 days | – |
Income Statement
| Metric | AUTL | EDIT |
|---|---|---|
| Total Revenue | $100M | $44M |
| Operating Income | -$247M | -$76M |
| R&D Expense | $113M | $85M |
| SG&A Expense | $153M | – |
| Cost of Goods Sold | $99M | – |
Dividend & Shareholder Information
| Metric | AUTL | EDIT |
|---|---|---|
| Shares Outstanding | 266M | 154M |
AUTL vs EDIT: stock comparison and AI forecast
Which is bigger, AUTL or EDIT?
AUTL and EDIT have similar market capitalizations ($377M and $399M).
Which stock performed better over the last six months, AUTL or EDIT?
Over the last six months AUTL returned -13.7% and EDIT -14.5%.
Which one does Intratio's AI model rank higher, AUTL or EDIT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.